Avenue Therapeutics Statistics
Total Valuation
ATXI has a market cap or net worth of 840,546. The enterprise value is -1.10 million.
| Market Cap | 840,546 |
| Enterprise Value | -1.10M |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATXI has 3.29 million shares outstanding. The number of shares has increased by 34.27% in one year.
| Current Share Class | 3.29M |
| Shares Outstanding | 3.29M |
| Shares Change (YoY) | +34.27% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 7.02% |
| Float | 2.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.48 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40
| Current Ratio | 1.40 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -164.83% and return on invested capital (ROIC) is -113.94%.
| Return on Equity (ROE) | -164.83% |
| Return on Assets (ROA) | -63.14% |
| Return on Invested Capital (ROIC) | -113.94% |
| Return on Capital Employed (ROCE) | -544.82% |
| Weighted Average Cost of Capital (WACC) | 3.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.78M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.13% in the last 52 weeks. The beta is -0.20, so ATXI's price volatility has been lower than the market average.
| Beta (5Y) | -0.20 |
| 52-Week Price Change | -18.13% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.53 |
| Relative Strength Index (RSI) | 42.22 |
| Average Volume (20 Days) | 4,842 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.10M |
| Pretax Income | -2.80M |
| Net Income | -2.78M |
| EBITDA | n/a |
| EBIT | -3.10M |
| Earnings Per Share (EPS) | -0.86 |
Balance Sheet
The company has 1.94 million in cash and no debt, with a net cash position of 1.94 million or 0.59 per share.
| Cash & Cash Equivalents | 1.94M |
| Total Debt | n/a |
| Net Cash | 1.94M |
| Net Cash Per Share | 0.59 |
| Equity (Book Value) | 569,000 |
| Book Value Per Share | 0.17 |
| Working Capital | 569,000 |
Cash Flow
| Operating Cash Flow | -1.38M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.27% |
| Shareholder Yield | -34.27% |
| Earnings Yield | -330.38% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.0133333.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0133333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |